Laurie Komuda
Family · Syracuse, NYNPI 1942759568
Payments from drug & device makers
Across 144 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$381
- AbbVie$334
- Johnson & Johnson$251
- Otsuka America Pharmaceutical, Inc.$207
- Lundbeck LLC$201
- Indivior Inc.$183
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,681100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 15 | $381 |
| AbbVie | 21 | $334 |
| Johnson & Johnson | 13 | $251 |
| Otsuka America Pharmaceutical, Inc. | 11 | $207 |
| Lundbeck LLC | 11 | $201 |
| Indivior Inc. | 11 | $183 |
| Teva Pharmaceuticals USA, Inc. | 11 | $179 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $167 |
| Alkermes, Inc. | 6 | $115 |
| Neurocrine Biosciences, Inc. | 5 | $73 |
| Orexo US, Inc. | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Pfizer | 4 | $68 |
| Medtronic | 3 | $67 |
| Corium, LLC | 4 | $65 |
| Boehringer Ingelheim | 2 | $44 |
| Amgen | 2 | $33 |
| Braeburn Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| AstraZeneca | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Novartis | 1 | $15 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$110
How this compares
$2,691 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 54 | $7,324 |
Paid to pharmacies, not to this prescriber.
Other family in Syracuse
- Jonathan LesuerSyracuse$172K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.